http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800220-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104800220-B
titleOfInvention It is a kind of to be used to release the endotoxic medicament composing prescription of Endophytic bacteria
abstract The present invention relates to a kind of for releasing the endotoxic medicament composing prescription of Endophytic bacteria, the medicament composing prescription is made up of the A and formula B that fills a prescription, and the raw material and its weight ratio of the A that fills a prescription are:14 parts of flunixin meglumine, 16 parts of vitamin C, the raw material and its weight ratio of the B that fills a prescription are:28 parts of ceftiofur sodium, 1.5 5 parts of Enrofloxacin.Wherein, injection of the flunixin meglumine for 0.05g/ml, injection of the vitamin C for 0.1g/ml, injection of the Enrofloxacin for 0.05g/ml, ceftiofur sodium is freeze drying powder injection.The medicament composing prescription can efficiently release the bacterial endotoxin cured the disease to animal, and there is high susceptibility to pathogenic bacteria such as Escherichia coli, actinobacillus pleuropneumoniae, haemophilus parasuis infections, energy effectively treatment is by the above-mentioned illnesss such as microbial oedema, contagious pleuropneumonia, heating, loss of appetite of causing a disease, evident in efficacy.
priorityDate 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71188
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71816151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452328128
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353636
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID622
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13385
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID622
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID738
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450836658
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553159
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553146
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114811

Total number of triples: 42.